Edwards Lifesciences Corporation Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount
Edwards Lifesciences Corporation (EW) reported Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount of $267.30 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate · last filed 2026-02-25
- Edwards Lifesciences Corporation effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2025 was $267.30M, a 17.78% decline from fiscal 2024.
- Edwards Lifesciences Corporation effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2024 was $325.10M, a 12.84% increase from fiscal 2023.
- Edwards Lifesciences Corporation effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2023 was $288.10M, a 11.00% decline from fiscal 2022.
- Edwards Lifesciences Corporation effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2022 was $323.70M, a 9.43% decline from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | $267.30M 10-K · filed 2026-02-25 | |
| 2024-12-31 | $325.10M 10-K · filed 2026-02-25 | |
| 2023-12-31 | $288.10M 10-K · filed 2026-02-25 | $335.60M 10-K · filed 2024-02-12 |
| 2022-12-31 | $323.70M 10-K · filed 2025-02-28 | $371.10M 10-K · filed 2023-02-13 |
| 2021-12-31 | $357.40M 10-K · filed 2024-02-12 | |
| 2020-12-31 | $192.50M 10-K · filed 2023-02-13 | |
| 2019-12-31 | $245.00M 10-K · filed 2022-02-14 | |
| 2018-12-31 | $159.90M 10-K · filed 2021-02-12 | |
| 2017-12-31 | $362.20M 10-K · filed 2020-02-14 | |
| 2016-12-31 | $258.30M 10-K · filed 2019-02-15 | |
| 2015-12-31 | $217.80M 10-K · filed 2018-02-16 | |
| 2014-12-31 | $400.40M 10-K · filed 2017-02-17 | |
| 2013-12-31 | $178.90M 10-K · filed 2016-02-19 | $180.30M 10-K · filed 2014-02-28 |
| 2012-12-31 | $135.90M 10-K · filed 2015-02-20 | $136.90M 10-K · filed 2013-02-28 |
| 2011-12-31 | $99.20M 10-K · filed 2014-02-28 | |
| 2010-12-31 | $93.90M 10-K · filed 2013-02-28 | |
| 2009-12-31 | $106.50M 10-K · filed 2012-02-27 | |
| 2008-12-31 | $57.50M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |